Bac-KLW

General Information


DRACP ID  DRACP02061

Peptide Name   Bac-KLW

Sequence  KLLKIWWIKVLK

Sequence Length  12

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
RAW 264.7 Mouse macrophage leukemia cell Leukemia <20% Killing=400 µg/ml MTT assay 2 days 1

Hemolytic Activity  Human erythrocytes: <10% Hemolysis=400 µg/ml

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02061

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C81H134N18O13

Absent amino acids  ACDEFGHMNPQRSTY

Common amino acids  K

Mass  176447

Pl  11.28

Basic residues  4

Acidic residues  0

Hydrophobic residues  8

Net charge  4

Boman Index  1110

Hydrophobicity  60

Aliphatic Index  186.67

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  11000

Absorbance 280nm  1000

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23109411

Title  Linear bactenecin analogs with cell selectivity and anti-endotoxic activity

Doi 10.1002/psc.2460

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPS_13538

DRACP is developed by Dr.Zheng's team.